REFRACTORY IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) TREATED WITH CYCLOSPORINE
P. Kelsey,K. Schofield,C. Geary
DOI: https://doi.org/10.1111/j.1365-2141.1985.tb07400.x
1985-05-01
British Journal of Haematology
Abstract:The immune cytopenias are usually the result of a disturbance of humoral immunity, and in the case ofITP, platelet antibodies can frequently be detected. The evidence that certain cases of immune granulocytopenia may result from cell mediated autoimmunity (Bagby et ul, 198 3). encouraged us to treat a case of refractory ITP with cyclosporine. This drug appears to block T-lymphocyte mediated responses by interfering with the function of interleukin-2 (Bendtzen & Peterson, 1982). A 28-year-old man presented in January 1983 with bleeding gums and extensive purpura. In spite of corticosteroid therapy (50 mg/d), he developed a cerebral haemorrhage within 24 h of hospital admission. The blood count showed severe thrombocytopenia: Hb 10.6 g/dl; WBC 12.6 x 109/l; platelets 2 x lOY/l. The bone marrow showed erythroid hyperplasia and an abundance of megakaryocytes. including many immature forms. No platelet antibodies could be detected using an ELISA technique, while laboratory tests for collagen disease were negative. Therapy with high-dose corticosteroids (prednisolone 100 mg/d) was continued; the platelet count rose to 103 x 1 09/1 and the cerebral haemorrhage slowly resolved. Unfortunately the platelet count fell to 5 x 10y/l within 2 weeks despite continuation of steroid therapy. Intravenous high-dose immunoglobulin (Newlands et aJ, 1983) had no effect and a splenectomy was carried out. This led to an improvement in platelet count lasting just 72 h. Subsequently therapy with prednisolone, azathioprine, danazol. plasma exchange and anti-lymphocyte globulin, both alone and in various combinations, have proved of little value. However, an intravenous injection of vincristine 1 mg has repeatedly proved effective, with a reproducible response. The platelet count rises to the normal range within 3-4 d, only to fall back after 7-10 d. A regimen of prednisolone 2 5 mg on alternate days, plus vincristine 1 mg every 10 d or so, has prevented life-threatening haemorrhage for the last 1 9 months, in spite of several periods of profound thrombocytopenia. Epilepsy secondary to cerebral haemorrhage has been controlled with phenytoin. Concern about the long-term effects of vincristine prompted us to seek an alternative approach. A trial of cyclosporine, 10 mg/kg/d in two divided doses, resulted in a slow improvement, initially manifested by a prolongation of the usually transient response to vincristine. After 4 weeks we were able to maintain the platelet count without further vincristine injections, and the steroid dosage has now been reduced to 12.5 mg on alternate days (the smallest dose since the onset of his illness). Cyclosporine plasma levels at the beginning of the treatment period ranged from 200 to 2 50 ng/ml, but for most of the treatment course plasma levels of 25-50 ng/ml were present. The platelet count remained around 100 x 10y/l for over 2 months, but began to fall, despite continued cyclosporine therapy, when further reduction in steroid dosage was attempted.